Job/Unit: O20945
/KAP1
Date: 10-09-12 10:58:00
Pages: 10
Domino Synthesis of Tetrasubstituted Furans
27.5 ppm. HRMS (MALDI): calcd. for C28H21Cl3O4Na [M +
Na]+ 549.0398; found 549.0402.
82.1, 27.6 ppm. HRMS (MALDI): calcd. for C22H18O7Na [M +
Na]+ 417.0945; found 417.0940.
tert-Butyl 4-(3-Chlorobenzoyl)-2,5-bis(3-chlorophenyl)furan-3-carb-
oxylate (3ac): tert-Butyl acrylate (1a, 0.5 mmol, 73 μL) and 3-
chlorobenzoyl chloride (2c, 1.8 mmol, 231 μL) were employed in
tert-Butyl 2,5-Di(thien-2-yl)-4-(thien-2-ylcarbonyl)furan-3-carboxyl-
ate (3ah): tert-Butyl acrylate (1a, 0.5 mmol, 73 μL) and 2-thenoyl
chloride (2h, 1.8 mmol, 178 μL) were employed in the typical pro-
cedure to give the product 3ah (106 mg, 48%); oil. 1H NMR
the typical procedure to give the product 3ac (261 mg, 99%); yellow
1
solid; m.p. 110–111 °C. H NMR (400 MHz, CDCl3): δ = 8.04 (s, (400 MHz, CDCl3): δ = 8.10 (dd, J = 3.8, 1.0 Hz, 1 H), 7.70 (dd,
1 H), 7.98 (s, 1 H), 7.95 (t, J = 4.4 Hz, 2 H), 7.83 (d, J = 7.8 Hz, J = 4.0, 0.9 Hz, 1 H), 7.60 (dd, J = 3.8, 0.9 Hz, 1 H), 7.49 (dd, J
1 H), 7.67 (s, 1 H), 7.55 (d, J = 8.2 Hz, 1 H), 7.38–7.46 (m, 4 H),
= 5.0, 1.0 Hz, 1 H), 7.45 (dd, J = 4.7, 0.9 Hz, 1 H), 7.33 (dd, J =
7.22–7.29 (m, 2 H), 1.23 (s, 9 H) ppm. 13C NMR (100 MHz, 5.0, 0.9 Hz, 1 H), 7.16 (dd, J = 5.0, 3.9 Hz, 1 H), 7.09 (dd, J = 4.7,
CDCl3): δ = 190.1, 161.1, 154.0, 149.2, 138.8, 135.1, 134.8, 134.2,
133.7, 130.3, 130.1, 130.1, 130.1, 129.9, 129.6, 129.2, 129.1, 128.4,
127.6, 126.6, 126.0, 124.2, 122.4, 117.9, 83.0, 27.5 ppm.
C28H21Cl3O4 (527.83): calcd. C 63.71, H 4.01; found C 63.41, H
3.67.
4.0 Hz, 1 H), 7.02 (dd, J = 5.0, 3.8 Hz, 1 H), 1.25 (s, 9 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 182.0, 160.6, 149.9, 144.9, 144.2,
133.6, 133.5, 129.4, 129.2, 128.4, 127.6, 127.3, 126.8, 126.6, 126.1,
125.7, 119.3, 113.8, 81.4, 26.5 ppm. HRMS (MALDI): calcd. for
C22H18S3O4Na [M + Na]+ 465.0529; found 465.0527.
tert-Butyl 4-(2-Chlorobenzoyl)-2,5-bis(2-chlorophenyl)furan-3-carb-
oxylate (3ad): tert-Butyl acrylate (1a, 0.5 mmol, 73 μL) and 2-
chlorobenzoyl chloride (2d, 1.8 mmol, 229 μL) were employed in
the typical procedure to give the product 3ad (96 mg, 36%); yellow
solid; m.p. 118–120 °C. 1H NMR (400 MHz, CDCl3): δ = 7.66 (dd,
J = 7.6, 1.8 Hz, 1 H), 7.61 (dd, J = 7.4, 1.8 Hz, 1 H), 7.61 (td, J =
7.6, 1.8 Hz, 2 H), 7.36–7.42 (m, 2 H), 7.28–7.34 (m, 2 H), 7.25–
7.28 (m, 2 H), 7.18–7.24 (m, 2 H), 1.22 (s, 9 H) ppm. 13C NMR
Methyl
4-(4-Chlorobenzoyl)-2,5-bis(4-chlorophenyl)furan-3-carb-
oxylate (3bb): Methyl acrylate (1b, 0.5 mmol, 45 μL) and 4-
chlorobenzoyl chloride (2b, 1.8 mmol, 229 μL) were employed in
the typical procedure to give the product 3bb (227 mg, 94%); yellow
1
solid; m.p. 185–186 °C. H NMR (400 MHz, CDCl3): δ = 7.99 (d,
J = 8.4 Hz, 2 H), 7.87 (d, J = 8.4 Hz, 2 H), 7.55 (d, J = 8.4 Hz, 2
H), 7.46 (d, J = 8.4 Hz, 2 H), 7.43 (d, J = 8.4 Hz, 2 H), 7.31 (d, J
= 8.4 Hz, 2 H), 3.50 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3):
(100 MHz, CDCl3): δ = 188.4, 161.2, 153.4, 152.9, 137.1, 134.2, δ = 190.6, 162.6, 155.1, 149.7, 140.3, 136.2, 135.7, 135.3, 130.4,
134.0, 133.2, 132.5, 132.3, 132.2, 131.5, 131.0, 130.8, 129.7, 129.7, 129.7, 129.2, 129.1, 128.7, 127.3, 127.0, 126.8, 122.0, 115.6,
129.7, 128.8, 128.0, 126.4, 126.3, 126.2, 124.9, 119.1, 81.8, 51.8 ppm. HRMS (MALDI): calcd. for C25H15Cl3O4Na [M +
27.6 ppm. HRMS (MALDI): calcd. for C28H21Cl3O4Na [M +
Na]+ 506.9928; found 506.9926.
Na]+ 549.0398; found 549.0392.
Methyl 4-(4-Methylbenzoyl)-2,5-di-p-tolylfuran-3-carboxylate (3be):
tert-Butyl
4-(4-Methylbenzoyl)-2,5-di-p-tolylfuran-3-carboxylate Methyl acrylate (1b, 0.5 mmol, 45 μL) and p-toluoyl chloride (2e,
(3ae): tert-Butyl acrylate (1a, 0.5 mmol, 73 μL) and 4-toluoyl chlor-
ide (2e, 1.8 mmol, 238 μL) were employed in the typical procedure
to give the product 3ae (230 mg, 97%); white solid; m.p. 160–
162 °C. 1H NMR (400 MHz, CDCl3): δ = 7.84 (d, J = 8.2 Hz, 2
H), 7.79 (d, J = 8.1 Hz, 2 H), 7.41 (d, J = 8.2 Hz, 2 H), 7.15 (d, J
1.8 mmol, 238 μL) were employed in the typical procedure to give
the product 3be (189 mg, 90%); yellow solid; m.p. 185–186 °C. H
1
NMR (400 MHz, CDCl3): δ = 7.93 (d, J = 8.0 Hz, 2 H), 7.85 (d,
J = 7.9 Hz, 2 H), 7.53 (d, J = 8.0 Hz, 2 H), 7.28 (d, J = 7.9 Hz, 2
H), 7.22 (d, J = 7.9 Hz, 2 H), 7.10 (d, J = 7.9 Hz, 2 H), 3.46 (s, 3
= 8.1 Hz, 2 H), 7.11 (d, J = 8.0 Hz, 2 H), 6.97 (d, J = 8.0 Hz, 2 H), 2.41 (s, 3 H), 2.37 (s, 3 H), 2.29 (s, 3 H) ppm. 13C NMR
H), 2.27 (s, 3 H), 2.24 (s, 3 H), 2.15 (s, 3 H), 1.06 (s, 9 H) ppm.
(100 MHz, CDCl3): δ = 192.1, 163.1, 155.9, 150.1, 144.2, 140.0,
13C NMR (100 MHz, CDCl3): δ = 191.8, 161.8, 155.4, 149.6, 144.3, 138.8, 135.2, 129.3, 129.3, 129.2, 129.0, 128.2, 126.2, 126.1, 125.8,
139.6, 138.6, 135.2, 129.6, 129.2, 129.2, 128.8, 128.2, 126.4, 126.2,
125.7, 121.4, 116.3, 81.9, 27.4, 21.6, 21.3, 21.1 ppm. HRMS
(MALDI): calcd. for C31H30O4Na [M + Na]+ 489.2036; found
489.2035.
121.39, 114.8, 51.4, 21.6, 21.4, 21.2 ppm. HRMS (MALDI): calcd.
for C28H24O4 [M]+ 424.1669; found 424.1667.
Ethyl 4-(4-Chlorobenzoyl)-2,5-bis(4-chlorophenyl)furan-3-carboxyl-
ate (3cb): Ethyl acrylate (1c, 0.5 mmol, 55 μL) and 4-chlorobenzoyl
chloride (2b, 1.8 mmol, 229 μL) were employed in the typical pro-
cedure to give the product 3cb (243 mg, 98%); white solid; m.p.
177–178 °C. 1H NMR (400 MHz, CDCl3): δ = 8.01 (d, J = 8.4 Hz,
2 H), 7.90 (d, J = 8.4 Hz, 2 H), 7.54 (d, J = 8.4 Hz, 2 H), 7.46 (t,
tert-Butyl
4-(4-Nitrobenzoyl)-2,5-bis(4-nitrophenyl)furan-3-carb-
oxylate (3af): tert-Butyl acrylate (1a, 0.5 mmol, 73 μL) and 4-nitro-
benzoyl chloride (2f, 1.8 mmol, 0.334 g) were employed in the typi-
cal procedure to give the product 3af (223 mg, 80%); yellow solid;
m.p. 179–180 °C. 1H NMR (400 MHz, CDCl3): δ = 8.38 (t, J = J = 8.4 Hz, 2 H), 7.44 (t, J = 8.4 Hz, 2 H),7.31 (d, J = 8.4 Hz, 2
8.6 Hz, 2 H), 8.36 (t, J = 8.6 Hz, 2 H), 8.30 (d, J = 8.6 Hz, 2 H),
H), 4.00 (q, J = 7.1 Hz, 2 H), 0.93 (t, J = 7.1 Hz, 3 H) ppm. 13C
8.23 (d, J = 8.6 Hz, 2 H), 8.18 (d, J = 8.6 Hz, 2 H), 7.79 (d, J = NMR (100 MHz, CDCl3): δ = 190.7, 162.1, 155.2, 149.4, 140.3,
8.6 Hz, 2 H), 1.22 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3): δ 136.2, 135.7, 135.2, 130.6, 129.8, 129.2, 129.1, 128.6, 127.2, 127.1,
= 189.3, 160.4, 156.4, 154.3, 150.9, 149.1, 148.4, 147.9, 141.1, 133.9,
133.5, 130.4, 129.5, 126.7, 124.4, 124.2, 123.7, 119.6, 84.2,
27.6 ppm. C28H21N3O10 (559.49): calcd. C 60.11, H 3.78, N 7.51;
found C 59.85, H 3.94, N 7.53.
126.9, 121.9, 115.8, 61.2, 13.4 ppm. HRMS (MALDI): calcd. for
C26H17Cl3O4Na [M + Na]+ 521.0085; found 521.0078.
Ethyl 4-(4-Methylbenzoyl)-2,5-di-p-tolylfuran-3-carboxylate (3ce):
Ethyl acrylate (1c, 0.5 mmol, 55 μL) and 4-toluoyl chloride (2e,
1.8 mmol, 238 μL) were employed in the typical procedure to give
the product 3ce (209 mg, 96%); white solid; m.p. 134–136 °C. 1H
NMR (400 MHz, CDCl3): δ = 7.95 (d, J = 7.9 Hz, 2 H), 7.88 (d,
J = 7.9 Hz, 2 H), 7.53 (d, J = 7.9 Hz, 2 H), 7.28 (d, J = 7.9 Hz, 2
tert-Butyl
2,5-Di(furan-2-yl)-4-(furan-2-ylcarbonyl)furan-3-carb-
oxylate (3ag): tert-Butyl acrylate (1a, 0.5 mmol, 73 μL) and 2-furoyl
chloride (2g, 1.8 mmol, 178 μL) were employed in the typical pro-
cedure to give the product 3ag (100 mg, 50%); oil. 1H NMR
(400 MHz, CDCl3): δ = 7.60 (dd, J = 16.0, 6.7 Hz, 3 H), 7.45 (s, 1 H), 7.23 (d, J = 7.9 Hz, 2 H), 7.10 (d, J = 7.9 Hz, 2 H), 3.97 (q, J
H), 7.13 (s, 1 H), 6.87 (d, J = 3.1 Hz, 1 H), 6.55–6.58 (m, 2 H),
6.45 (d, J = 1.4 Hz, 1 H), 1.29 (s, 9 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 177.4, 160.9, 153.3, 147.1, 146.8, 144.0, 143.8, 143.5,
143.4, 143.2, 119.5, 119.1, 114.8, 114.2, 112.51, 112.0, 111.6, 110.4,
= 7.0 Hz, 2 H), 2.41 (s, 3 H), 2.38 (s, 3 H), 2.29 (s, 3 H), 0.90 (t, J
= 7.0 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 192.2,
162.7, 156.0, 149.9, 144.3, 139.9, 138.8, 135.3, 129.4, 129.3, 129.3,
128.9, 128.4, 126.2, 126.1, 125.8, 121.4, 114.9, 60.7, 21.7, 21.4, 21.2,
Eur. J. Org. Chem. 0000, 0–0
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5